A big inflation report is on the way Wednesday. Here’s what to expect

A big inflation report is on the way Wednesday. Here’s what to expect


A person browses a grocery store following the announcement of tariffs on Canadian and Mexican goods by U.S. President Donald Trump, in Toronto, Ontario, Canada, on March 4, 2025.

Arlyn Mcadorey | Reuters

With concerns running high that President Donald Trump’s tariff policies will aggravate inflation, a report Wednesday could deliver some mildly encouraging news.

The consumer price index for February is forecast to show an increase of 0.3% for a broad array of goods and services across the largest economy in the world. That projection holds both for the all-items measure and the core index that excludes volatile food and energy prices.

On an annual basis, that would put headline inflation at 2.9% and the core reading at 3.2%, both 0.1 percentage point lower than in January.

The good news is those rates represent a continuation of a steady but quite slow drawdown in the inflation rate over the past year. The bad news is that both also are still well above the Federal Reserve’s 2% goal, likely keeping the central bank on hold again when it meets next week.

“We expect broad-based deceleration, with weaker core goods and services,” Morgan Stanley economist Diego Anzoategui said in a note. “Why still elevated? For three reasons: (1) we expect used car prices rise because of past wildfires, (2) according to our analysis, certain goods and services show residual seasonality in February, and (3) we think supply constraints keep airfares inflation elevated in February.”

The big question now is where things head from here.

Trump’s tariff moves have stirred market worries of both rising inflation and slower economic growth. With Fed officials historically more attuned to the inflation side of the dual mandate for price stability and full employment, a prolonged period of high prices could put the Fed on the sidelines for longer.

However, Federal Reserve Chair Jerome Powell and his colleagues have indicated that in their view, tariffs historically have been one-off price increases and not fundamental inflation drivers. If that’s also the case this time, policymakers might look through any price blips from trade policy and continue to lower rates, as markets are projecting this year.

Goldman Sachs economists expect the Fed to stay on hold until policy comes into clearer view, then likely lower the central bank’s benchmark lending rate by a half percentage point later this year.

“We see further disinflation in the pipeline from rebalancing in the auto, housing rental, and labor markets, though we expect offsets from catch-up inflation in healthcare and a boost from an escalation in tariff policy,” the firm said in a note.

The Bureau of Labor Statistics will release the CPI report at 8:30 a.m. ET.

Don’t miss these insights from CNBC PRO



Source

Oil prices rise more than 2% as Trump weighs strikes on Iran
World

Oil prices rise more than 2% as Trump weighs strikes on Iran

Crude oil prices rose more than 2% on Thursday as President Donald Trump weighed military strikes on OPEC member Iran. U.S. crude rose $1.56, or 2.5%, to $64.77 per barrel. Global benchmark Brent was up $1.59, or 2.3%, to $69.99 per barrel. Multiple sources told Reuters that Trump is weighing targeted strikes on Iranian security […]

Read More
India bets on up to 7.2% growth next year, outpacing most major economies
World

India bets on up to 7.2% growth next year, outpacing most major economies

Laborers work at a coastal road project construction site in Mumbai on January 12, 2022. Punit Paranjpe | Afp | Getty Images India has forecasted its economy to grow between 6.8% to 7.2% in the fiscal year 2027, outpacing most major economies. The world’s fourth-largest economy is targeting this growth on the back of a […]

Read More
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite
World

Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite

Drugmakers Roche and Sanofi’s latest earnings were largely as expected, with the companies talking up the potential of experimental medicines ahead of a looming “patent cliff” for Big Pharma. Both companies’ stocks were down less than 1% on Thursday after reporting earnings before the bell. They are both among the pharmaceutical companies that could see […]

Read More